Analysis of the advantage features of Beijing surveillance network for Creutzfeldt-Jakob disease

REFERENCES

• Liberski PP. Historical overview of prion diseases: a view from afar. Folia Neuropathol 2012; 50:1-12; PMID:22505359
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363-83; PMID:9811807; http://dx.doi.org/10.1073/pnas.95.23.13363
   PubMed Web of Science ®Google Scholar
• Fraser PE. Prions and prion-like proteins. J Biol Chem 2014; 289:19839-40; PMID:24860092; http://dx.doi.org/10.1074/jbc.R114.583492
   PubMed Web of Science ®Google Scholar
• Appleby BS, Rincon-Beardsley TD, Appleby KK, Crain BJ, Wallin MT. Initial diagnoses of patients ultimately diagnosed with prion disease. J Alzheimers Dis 2014; 42:833-9; PMID:24934543
   PubMed Web of Science ®Google Scholar
• Wieser HG, Schindler K, Zumsteg D. EEG in Creutzfeldt-Jakob disease. Clin Neurophysiol 2006; 117:935-51; PMID:16442343; http://dx.doi.org/10.1016/j.clinph.2005.12.007
   PubMed Web of Science ®Google Scholar
• Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, Konno H, Doh-ura K, Mugikura S, Tamura H, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004; 63:443-9; PMID:15304574; http://dx.doi.org/10.1212/01.WNL.0000134555.59460.5D
   PubMed Web of Science ®Google Scholar
• Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D, Will RG, Knight RS, Green AJ. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry 2010; 81:1243-8; PMID:20855493; http://dx.doi.org/10.1136/jnnp.2009.197962
   PubMed Web of Science ®Google Scholar
• Chitravas N, Jung RS, Kofskey DM, Blevins JE, Gambetti P, Leigh RJ, Cohen ML. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol 2011; 70:437-44; PMID:21674591; http://dx.doi.org/10.1002/ana.22454
   PubMed Web of Science ®Google Scholar
• Satoh K, Tobiume M, Matsui Y, Mutsukura K, Nishida N, Shiga Y, Eguhchi K, Shirabe S, Sata T. Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease. Lab Invest 2010; 90:1637-44; PMID:20697380; http://dx.doi.org/10.1038/labinvest.2009.68
   PubMed Web of Science ®Google Scholar
• Budka H. Neuropathology of prion diseases. Br Med Bull 2003; 66:121-30; PMID:14522854; http://dx.doi.org/10.1093/bmb/66.1.121
   PubMed Web of Science ®Google Scholar
• Takada LT, Geschwind MD. Prion diseases. Semin Neurol 2013; 33:348-56; PMID:24234356; http://dx.doi.org/10.1055/s-0033-1359314
   PubMed Web of Science ®Google Scholar
• Gao C, Shi Q, Tian C, Chen C, Han J, Zhou W, Zhang BY, Jiang HY, Zhang J, Dong XP. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One 2011; 6:e24231; PMID:21904617; http://dx.doi.org/10.1371/journal.pone.0024231
   PubMed Web of Science ®Google Scholar
• Newey CR, Sarwal A, Wisco D, Alam S, Lederman RJ. Variability in diagnosing Creutzfeldt-Jakob disease using standard and proposed diagnostic criteria. J Neuroimaging 2013; 23:58-63; PMID:23163590; http://dx.doi.org/10.1111/j.1552-6569.2012.00763.x
   PubMed Web of Science ®Google Scholar
• Chen C, Wang JC, Shi Q, Zhou W, Zhang XM, Zhang J, Tian C, Gao C, Dong XP. Analyses of the survival time and the influencing factors of chinese patients with prion diseases based on the surveillance data from 2008-2011. PLoS One 2013; 8:e62553; PMID:23671608; http://dx.doi.org/10.1371/journal.pone.0062553
   PubMed Web of Science ®Google Scholar
• Shi Q, Gao C, Zhou W, Zhang BY, Chen JM, Tian C, Jiang HY, Han J, Xiang NJ, Wang XF, et al. Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007. BMC Public Health 2008; 8:360; PMID:18928564; http://dx.doi.org/10.1186/1471-2458-8-360
   PubMed Web of Science ®Google Scholar
• Panegyres PK, Armari E. Therapies for human prion diseases. Am J Neurodegener Dis 2013; 2:176-86; PMID:24093082
   PubMedGoogle Scholar
• Krasnianski A, Kaune J, Jung K, Kretzschmar HA, Zerr I. First symptom and initial diagnosis in sporadic CJD patients in Germany. J Neurol 2014; 261:1811-7; PMID:25022936; http://dx.doi.org/10.1007/s00415-014-7410-z
   PubMed Web of Science ®Google Scholar